Our previous studies showed that aberrant expression of PLOD2 was detected in BC and renal cell carcinoma tissues, and its overexpression enhanced cancer cell malignant transformation (Kurozumi et al., 2016; Miyamoto et al., 2016). This evidence concerns the gene PLOD2 and hereditary clear cell renal cell carcinoma.